Catalyst Wire Dossier Catalyst Wire Dossier

BT01001 Ophthalmic Solution

BT01001 · Beyang Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BT01001 Ophthalmic Solution, covering 2026-01-02 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Safety of BT01001 Ophthalmic Solution [Phase 1]

See pricing